Authors: Ressing, ME van Driel, WJ Brandt, RMP Kenter, GG de Jong, JH Bauknecht, T Fleuren, GJ Hoogerhout, P Offringa, R Sette, A Celis, E Grey, H Trimbos, BJ Kast, WM Melief, CJM

Citation: Me. Ressing et al., Detection of T helper responses, but not of human papillomavirus-specific cytotoxic T lymphocyte responses, after peptide vaccination of patients with cervical carcinoma, J IMMUNOTH, 23(2), 2000, pp. 255-266

Authors: van Driel, WJ Ressing, ME Kenter, GG Brandt, RMP Krul, EJT van Rossum, AB Schuuring, E Offringa, R Bauknecht, T Tamm-Hermelink, A van Dam, PA Fleuren, GJ Kast, WM Melief, CJM Trimbos, JB

Citation: Wj. Van Driel et al., Vaccination with HPV16 peptides of patients with advanced cervical carcinoma: Clinical evaluation of a phase I-II trial, EUR J CANC, 35(6), 1999, pp. 946-952

Authors: van Driel, WJ Kenter, GG Fleuren, GJ Melief, CJM Trimbos, BJ

Citation: Wj. Van Driel et al., Immunotherapeutic strategies for cervical squamous carcinoma, HEMAT ONCOL, 13(1), 1999, pp. 259

Authors: van Driel, WJ Kievit-Tyson, P van den Broek, LCJM Zwinderman, AH Trimbos, BJ Fleuren, GJ

Citation: Wj. Van Driel et al., Presence of an eosinophilic infiltrate in cervical squamous carcinoma results from a type 2 immune response, GYNECOL ONC, 74(2), 1999, pp. 188-195